Final hours! Save up to 55% OFF InvestingProCLAIM SALE

European shares dip; FTSE 100 outperforms on UK vaccine approval

Published 12/02/2020, 03:17 AM
Updated 12/02/2020, 04:45 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt
DE40
-
PFE
-
STOXX
-

By Susan Mathew

(Reuters) - European shares slipped on Wednesday as investors took stock following a near 14% rally last month, while shares in BioNTech surged after UK became the first country to approve its COVID-19 vaccine developed with Pfizer (NYSE:PFE).

London's blue-chip index outperformed regional peers, up 0.1% after Britain said the vaccine will be rolled out from next week, and as the pound slid on Brexit trade deal uncertainty.

"As vaccines get approved and rolled out, the outlook for the economy should improve," said Simona Gambarini, markets economist at Capital Economics.

The FTSE 100 has been inching towards pre-pandemic levels, having recovered 60% from March lows.

BioNtech's Frankfurt-listed shares jumped 7.5%, compared with a 0.5% fall for Germany's benchmark DAX index. Data showing a higher-than-expected rebound in retail sales in Europe's largest economy in October did little to cheer investors.

The pan-European STOXX 600 index was down 0.3%, with auto stocks leading declines as carmaker Volkswagen (DE:VOWG_p) slipped 2.1% amid uncertainty about top management.

"(The moves) come against the backdrop of a few weeks of very sharp rallies in European markets on the vaccine, so it's not unusual that there will be days when the rally moderates slightly," Gambarini said.

"I certainly don't think this will be the beginning of a correction, as more positive news will probably be coming our way regarding the vaccines."

Stimulus developments were also on the radar after the New York Times reported that U.S. President elect Joe Biden said his priority was getting a generous coronavirus aid package through Congress even before he takes office in January.

Biden added he will not act immediately to remove the Phase 1 trade agreement with China reached by President Donald Trump, according to the report. A tariff war between the world's two biggest economies had roiled markets and slowed global economic growth.

Investors also kept an eye on moves by Britain and the European Union as Brexit trade talks were still stuck.

© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

"A deal still hangs in the balance" the EU's Brexit negotiator said on Wednesday. The bloc had said it would launch contingency measures on Wednesday or Thursday, if unable to reach an agreement by then.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.